Please provide your email address to receive an email when new articles are posted on . In an analysis of the ISAR-CLOSURE trial, use of vascular closure devices was as safe and effective as manual ...

A California-based medical device company that makes a femoral artery access device is seeking $19 million and has raised $16.5 million of that, according to a regulatory filing. Arstasis makes the ...

Please provide your email address to receive an email when new articles are posted on . HOLLYWOOD, Fla. — While there is not yet definitive evidence that vascular closure devices produce better ...

Innovative Patient-Friendly Device Combines Safety of Extravascular Sealant and Security of Mechanical Closure to Provide Consistent Results “We are proud of the advantages Mynx Ace offers to femoral ...

Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...

Durham, NC - The benefits of femoral arteriotomy-closure devices (ACDs) remain uncertain, and better randomized trials are needed to determine which patients are most likely to benefit from them, ...

Cardiva Medical raised $30 million in equity, which will bankroll the commercial expansion of its bioabsorbable vascular closure system and advance technologies in its pipeline. The company’s Vascade ...

Closer monitoring of databases for tracking complications of medical devices may turn up more problems, a new study suggests. The U.S. Food and Drug Administration often sets up surveillance databases ...

Complications may arise at any stage of the procedure, and while they commonly relate to vascular access, can also result from trauma during device tracking, positioning or deployment. Furthermore, ...